Web3 security company GoPlus Security pointed out that there has been a recent surge in smart contract vulnerability attacks, particularly targeting older contracts that have been deployed for many years. Attackers are leveraging AI technology to quickly discover and exploit these vulnerabilities.
Recent typical incidents include:
GoPlus Security believes that traditional auditing methods are insufficient to effectively cover legacy contracts, and adopting AI-based Always-on Audit services may be the most effective solution currently available, capable of conducting security checks on old contracts in a short period while balancing reliability and cost.
This content is provided for general informational purposes only and doesn't constitute financial, investment, legal, or tax advice. Any events, rewards, online promotions, or related information mentioned herein should not be considered a recommendation, solicitation, or invitation to purchase, sell, trade, or otherwise deal in any crypto assets. Crypto assets are highly volatile and may result in loss. The availability of WEEX services, products, and related events may vary by region. You are responsible for ensuring that your participation is in accordance with applicable local laws and regulations.




























Moderna shares more than doubled on 19 August 2026 after Merck and Moderna said the Phase 3 INTerpath-001 trial of intismeran autogene plus KEYTRUDA met its recurrence-free survival endpoint in resected melanoma. This page explains what the result is, why the stock reacted this hard, what is still unknown, which dates come next (presentation and earnings, both unconfirmed), and what a trader can actually do on WEEX — which does not list Moderna; the nearest instrument is the XBI-USDT biotech ETF perpetual. No price targets, no forecasts.

